• No results found

Dose Calculation

In document 4875.pdf (Page 83-87)

Calculation of delivered dose is a well-established part of radiation therapy planning. CT intensities are based on the absorptivity of tissue to radiation, so it is possible to calculate the amount of energy a given beam deposits in each portion of tissue it passes through or near, taking into account the attenuation of the beam and the scattering of radiation into neighboring tissue. I use the treatment planning system known as PlanUNC [Schreiber et al., 2006] to calculate dose. Dose calculations for treatment planning are expected to be ±3% compared to measurements.

These calculations are most commonly used in treatment planning. But when images are available for treatment fractions, dose can be calculated for those days too. Then, if a mapping can be constructed between the image of each treatment fraction and a common reference frame, the dose can be accumulated to determine the total amount of radiation received by each portion of the tissue. My approach is a reversal of the most common methods of dose accumulation. Taking the planning image as given, I derive a deformation first and derive the treatment image from it, rather than acquiring a treatment image first and then deriving the deformation.

4.5

Experiments

I evaluated my method on four patient data sets, which contain eight, six, seven, and six treatment fractions, respectively. The data for each patient consist of a planning image, treatment images, and Calypso marker locations during treatment. Note that for each treatment fraction, the patient is positioned in the treatment machine according to the Calypso origin, which also serves as the isocenter of the treatment plan (i.e., the point in the space where the central beam of radiation passes), and treatment images are taken only for comparison with estimated images. Since the treatment images are taken before the patient is positioned for treatment, they are visually aligned to the Calypso marker locations before the comparison with estimated images and the non-rigid image registration for dose calculation.

4.5.1

Comparison of Organ Surfaces

In order to assess the similarity between the estimated image and real treatment image, I create an m-rep of the prostate for each treatment image based on the gray-scale image and user-specified landmarks. The estimated m-rep (mmarker, reference m-rep fitted to

the marker locations) is then compared to the treatment m-rep (mtreat, m-rep created

Table 4.1: Average errors in prostate surface and volume for the four patient data sets. The surface error is measured with average distance between two sets of sample points (D), and the volume overlap is measured with the ratio of intersection and union of the two volumes (IntersectionUnion ).

M-reps-based FEM-based Patient D(cm) IntersectionUnion D (cm) IntersectionUnion

1 0.08 0.90 0.07 0.91 2 0.04 0.93 0.07 0.90 3 0.10 0.85 0.06 0.90 4 0.04 0.95 0.05 0.94

with the treatment image) by computing the distance between sample points on the surfaces. For each sample point p on the surface of mtreat, its distance to the m-rep

mmarker is approximated as D(p, Bmarker) = min{d(p, q)|q∈Bmarker}, where Bmarker is

the set of sample points on the surface of mmarker, and d(p, q) is the Euclidean distance

between the two pointspandq. For the surface deformed by the FE simulation, I use the surface nodes of the prostate in the volumetric mesh as the sample points. The quality of object matching can also be measured in terms of the ratio of intersection and union of the two volumes, which takes the value in [0,1], with the value one representing a perfect match, and zero meaning no overlap. Fig. 4.1 shows the average surface distances and volume overlap of the treatment prostate estimated using the two methods.

Note that these average distances are within the image resolution of the four data sets; two of them are 0.12×0.12×0.3 cm, and the other two are 0.12×0.12×0.3 cm. Fig. 4.6 shows an example visual comparison of the estimated image (using m-reps and the simulation-based scheme) and corresponding treatment image.

4.5.2

Comparison of Calculated Dose

The dose calculation using the estimated image is compared against the dose calculated with real treatment images to evaluate the accuracy of my method. The non-rigid transformation with the treatment images is computed in the same manner as with

(a) Image estimated using fitted m-reps

(b) Comparison of (a) and real treatment image

(c) Image estimated using simulation-based optimization scheme

(d) Comparison of (c) and real treatment image

Figure 4.6: Axial (left), coronal (center), and sagittal (right) views of an example m-rep comparison; blue contour: m-rep fitted to Calypso marker locations during the treatment fraction; green contour: surface deformed by the simulation-based scheme; red contour: m-rep created with real treatment image; the green crosshairs show the Calypso origin, which also serves as the isocenter of the treatment plan; (a, c) CT images estimated using fitted m-reps and the simulation-based scheme, respectively; (b, d) 4×4 checkerboard images comparing (a) and (c) to the real treatment image, respectively.

the image estimated using m-reps, as described in Section 4.2.2. The dose calculation is based on radiotherapy plans with the radiation beam targeting at volumes with different margins around the prostate (5 mm, 7 mm, 9 mm, 11 mm, and 13 mm). I consider the dose in the prostate and in the anterior rectal wall (the part of the rectum right next to the prostate). Fig. 4.7 shows the differential and cumulative dose-volume histograms (DVH) of one of the data sets using the estimated images and real treatment images (with 5 mm margin). Besides visual similarity, I also numerically compare the DVHs by considering the equivalent uniform dose (EUD) [Wu et al., 2002] of the differential DVHs, as shown in Tables 4.2 and 4.3, along with the errors of the values given by my methods relative to those given by the real images. There are no generally accepted standards for errors in calculating delivered dose, but ±5% is a reasonable goal. I observed relative errors of less than 3.2% in EUD for the four patient data sets I experimented on.

In document 4875.pdf (Page 83-87)

Related documents